SCHEMBL18909445

SCHEMBL18909445

CCC(=O)N1CCC(CN2CCN(C(=O)COC)CC2)CC1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CACNA2D1 P54289 2/20 0.42
CACNA1B Q00975 2/20 0.42
CACNB1 Q02641 2/20 0.42
CACNA1C Q13936 1/20 0.42
BDKRB1 P46663 2/20 0.41
DRD3 P35462 1/20 0.40
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
EPHX2 P34913 3/20 0.39
HSD11B1 P28845 1/20 0.38
KMT2A Q03164 1/20 0.38
EPHX1 P07099 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
HTR4 Q13639 1/20 0.38
POLB P06746 1/20 0.38
PKM P14618 1/20 0.37
OPRK1 P41145 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24521470 0.87 CACNA2D1 (0.44) CACNA2D1CACNA1BCACNB1CACNA1CBDKRB1
SCHEMBL18909455 0.85 PKM (0.43) CACNA2D1CACNA1BCACNB1CACNA1CDRD3
SCHEMBL22030475 0.85 CNR1 (0.41) CACNA2D1CACNA1BCACNB1CACNA1CBDKRB1
SCHEMBL22030875 0.85 KDM4E (0.54) CACNA2D1CACNA1BCACNB1CACNA1CALDH1A1
SCHEMBL21280979 0.85 HRH2 (0.41) CACNA2D1CACNA1BCACNB1CACNA1CBDKRB1
SCHEMBL20471042 0.84 HRH3 (0.48) CACNA2D1CACNA1BCACNB1CACNA1CDRD3
SCHEMBL18909449 0.83 CACNA2D1 (0.45) CACNA2D1CACNA1BCACNB1CACNA1CALDH1A1
SCHEMBL22891216 0.82 CACNA2D1 (0.46) CACNA2D1CACNA1BCACNB1CACNA1CBDKRB1
SCHEMBL24521471 0.82 HSD11B1 (0.47) CACNA2D1CACNA1BCACNB1CACNA1CEPHX2
SCHEMBL25701777 0.81 HSD11B1 (0.53) CACNA2D1CACNA1BCACNB1CACNA1CALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3596072-B1 PYRAZOLOCHLOROPHENYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF HOFFMANN LA ROCHE (CH) 2022-06-22 EP disclosed
EP-3416967-B1 THERAPEUTIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF HOFFMANN LA ROCHE (CH) 2022-02-09 EP disclosed
EP-3380474-B1 JANUS KINASES INHIBITORS, COMPOSITIONS THEREOF AND USE THEREOF HOFFMANN LA ROCHE (CH) 2019-08-21 EP disclosed
WO-2017140825-A1 THERAPEUTIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-08-24 WO disclosed
WO-2017089390-A1 JANUS KINASES INHIBITORS, COMPOSITIONS THEREOF AND USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-06-01 WO disclosed